micorequities new report

www.microequities.com.au

Clover Corporation (ASX:CLV) has provided its investors an excellent business with strong organic growth. Under the leadership of CEO Dr. Ian Brown, the company has increased its sales from $16m in FY07 to $33m in FY11. Profitability during that period rose from $0.6m to a record $4.2m. The growth is particularly impressive given it occurred during a period of immense financial instability and the GFC. But the growth exemplifies the defensive qualities in Clover’s end products which cater to the infant food formula market and particularly the emerging markets in Asia. Our new report signals Clover is yet again about to embark on a period of significant organic growth, curiously at a time when financial market volatility seems to have been revived. Reinforcing the the view that Clover presents investors with a vehicle of defensive growth.